Nightmare Disorder
Nightmare disorder, also known as dream anxiety disorder, is a sleep disorder characterized by frequent nightmares. The nightmares, which often portray the individual in a situation that jeopardizes their life or personal safety, usually occur during the REM stages of sleep.
Cluster Number:
Wiki Number: PW136
Diagnosis: Nightmare Disorder
US Patients: 4% of adults; 1% of children
World Patients:
Sex Ratio: M;W2
Age Onset:
Brain Area:
Symptoms: frequent nightmares involving personal safety, usually occurring during REM stages of sleep; remembers every detail of the dream
Progression: does not wake up screaming, but reduce daytime efficiencies from being “tired”; fear and physical aggression are the most common
Causes: PTSD, extreme stress, death of a loved one; 30% have other psychiatric illnesses
Medications: several antipsychotic medicines have reduced nightmares; hypnosis and relaxation may also help
Therapies: EMDR (Eye Movement Desensitization and Reprocessing) have helped portions of those with PTSD or other threatening experiences.
Youtube Video: Nightmares and Treatment
Amazon or Library Book: Nightmareland
Click the book to link or buy from Amazon.
Support Group: sleepeducation.org; 630-737-9700
(American Academy of Sleep Medicine)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Factors impacting prazosin efficacy for nightmares and insomnia in PTSD patients - a systematic review and meta-regression analysisby Thaís Pereira Mendes on January 19, 2025
Posttraumatic stress disorder (PTSD) is a debilitating condition affecting 5.7 % of the global population in their lifetime. There is a strong association between trauma-related nightmares and insomnia with higher rates of physical illness, mental distress, and suicide among PTSD patients. Prazosin, an α1-adrenergic antagonist, has shown mixed results in treating these sleep disturbances. This study aims to evaluate the effect of prazosin compared to placebo on insomnia, nightmares, and global...
- Prevalence and associations of self-reported sleep problems in a large sample of patients with Parkinson's diseaseby Ziba Asadpoordezaki on January 19, 2025
Sleep problems are important comorbid features of, and risk factors for, neurodegenerative diseases such as Parkinson's disease (PD). To assess the prevalence and associations of sleep problems in patients with PD we analysed data from almost 54,000 participants in the Fox Insight study, including data from 38,588 patients with PD. Sleep problems are common in PD, with ~84% of respondents with PD reporting difficulty falling or staying asleep. Experiences of insomnia, restless leg syndrome,...
- The Clinical Neuroscience of Lucid Dreamingby Sofia Tzioridou on January 16, 2025
During most dreams, the dreamer does not realize that they are in a dream. In contrast, lucid dreaming allows to become aware of the current state of mind, often accompanied by considerable control over the ongoing dream episode. Lucid dreams can happen spontaneously or be induced through diverse behavioural, cognitive or technological strategies. Such induction techniques have spurred research into the potential therapeutic aspects of lucid dreams. In this review, we gather evidence on the link...
- Behind closed eyes: Understanding nightmares in children and adolescents with autism spectrum disorder - A systematic reviewby Elisa Pellegrini on January 16, 2025
INTRODUCTION: Brain and sleep development in childhood shapes emotional and cognitive growth, including the ability to recall dreams. In line with the continuity hypothesis of dreaming, several findings suggest a link between clinical symptoms and nightmare frequency. Sleep disorders and anxiety are among the most frequently co-occurring conditions in children and adolescents with autism spectrum disorder (ASD). However, their impact on nightmares has not yet been systematically explored. This...